These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 19205420)

  • 1. [Histopathologic diagnosis of luminal and basal type breast cancer].
    Sarcević B
    Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
    Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Mamessier E; Adélaïde J; Debono S; Houvenaeghel G; Maraninchi D; Viens P; Charpin C; Jacquemier J; Birnbaum D
    Cancer Res; 2006 May; 66(9):4636-44. PubMed ID: 16651414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
    Möllerström E; Delle U; Danielsson A; Parris T; Olsson B; Karlsson P; Helou K
    Cancer Genet Cytogenet; 2010 Apr; 198(2):79-89. PubMed ID: 20362222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
    González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
    Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
    Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
    Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathologic aspects of basal-like breast cancers.
    Fadare O; Tavassoli FA
    Nat Clin Pract Oncol; 2008 Mar; 5(3):149-59. PubMed ID: 18212769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic applications of gene expression signatures in breast cancer.
    Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
    Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
    Ruckhäberle E; Rody A; Engels K; Gaetje R; von Minckwitz G; Schiffmann S; Grösch S; Geisslinger G; Holtrich U; Karn T; Kaufmann M
    Breast Cancer Res Treat; 2008 Nov; 112(1):41-52. PubMed ID: 18058224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences and molecular immunohistochemical parameters in the subtypes of infiltrating ductal breast cancer.
    Bertolo C; Guerrero D; Vicente F; Cordoba A; Esteller M; Ropero S; Guillen-Grima F; Martinez-Peñuela JM; Lera JM
    Am J Clin Pathol; 2008 Sep; 130(3):414-24. PubMed ID: 18701415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer.
    Yakirevich E; Samkari A; Holloway MP; Lu S; Singh K; Yu J; Fenton MA; Altura RA
    Hum Pathol; 2012 Jun; 43(6):865-73. PubMed ID: 22055399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes.
    Vanden Bempt I; Vanhentenrijk V; Drijkoningen M; De Wolf-Peeters C
    J Pathol; 2006 Mar; 208(4):486-94. PubMed ID: 16402338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of tumour cell-associated uPAR expression in invasive ductal breast carcinoma.
    Kotzsch M; Bernt K; Friedrich K; Luther E; Albrecht S; Gatzweiler A; Magdolen V; Baretton G; Zietz C; Luther T
    Histopathology; 2010 Sep; 57(3):461-71. PubMed ID: 20840675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features.
    Ishihara A; Tsuda H; Kitagawa K; Yoneda M; Shiraishi T
    Breast Cancer; 2009; 16(3):179-85. PubMed ID: 19466513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.
    Weigelt B; Kreike B; Reis-Filho JS
    Breast Cancer Res Treat; 2009 Sep; 117(2):273-80. PubMed ID: 18815879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.